Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis.

• Graetz C Department of Neurology and Neuroimaging Center (NIC), Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
• Gröger A Department of Neurology and Neuroimaging Center (NIC), Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
• Luessi F Department of Neurology and Neuroimaging Center (NIC), Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
• Salmen A Department of Neurology, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany; Department of Neurology, Bern University Hospital, University of Bern, Bern, Switzerland.
• Zöller D Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany/Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
• Schultz J Department of Neurology and Neuroimaging Center (NIC), Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
• Siller N Department of Neurology and Neuroimaging Center (NIC), Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
• Fleischer V Department of Neurology and Neuroimaging Center (NIC), Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
• Bellenberg B Department of Radiology and Nuclear Medicine, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany.
• Berthele A Department of Neurology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
• Biberacher V Department of Neurology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany/TUM-NIC Neuroimaging Center, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
• Havla J Institute of Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig Maximilians University, Munich, Germany.
• Hecker M Department of Neurology, University of Rostock, Rostock, Germany.
• Hohlfeld R Institute of Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig Maximilians University, Munich, Germany/Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
• Infante-Duarte C NeuroCure Clinical Research Center, Department of Neurology and Experimental and Clinical Research Center and Max Delbrück Center for Molecular Medicine, Charité-University Medicine Berlin, Berlin, Germany.
• Kirschke JS Department of Neuroradiology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
• Kümpfel T Institute of Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig Maximilians University, Munich, Germany.
• Linker R Department of Neurology, University Hospital Erlangen, Erlangen, Germany.
• Paul F NeuroCure Clinical Research Center, Department of Neurology and Experimental and Clinical Research Center and Max Delbrück Center for Molecular Medicine, Charité-University Medicine Berlin, Berlin, Germany.
• Pfeuffer S Department of Neurology, University of Münster, Münster, Germany.
• Sämann P Max Planck Institute of Psychiatry, Munich, Germany.
• Toenges G Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
• Weber F Max Planck Institute of Psychiatry, Munich, Germany; Neurological Clinic, Medical Park, Bad Camberg, Germany.
• Zettl UK Department of Neurology, University of Rostock, Rostock, Germany.
• Jahn-Eimermacher A Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany/Darmstadt University of Applied Sciences, Darmstadt, Germany.
• Antony G Institute of Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig Maximilians University, Munich, Germany.
• Groppa S Department of Neurology and Neuroimaging Center (NIC), Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
• Wiendl H Department of Neurology, University of Münster, Münster, Germany.
• Hemmer B Department of Neurology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany/Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
• Mühlau M Department of Neurology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany/TUM-NIC Neuroimaging Center, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
• Lukas C Department of Radiology and Nuclear Medicine, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany.
• Gold R Department of Neurology, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany.
• Lill CM Department of Neurology and Neuroimaging Center (NIC), Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany/Genetic and Molecular Epidemiology Group, Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
• Zipp F Department of Neurology and Neuroimaging Center (NIC), Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Show more…

MRI

Neurodegeneration

SNP

brain atrophy

genetics

gray matter

risk factor

smoking

Adolescent

Adult

Aged

Apolipoproteins E

Atrophy

Body Mass Index

Brain

Female

Genetic Predisposition to Disease

HLA-DRB1 Chains

Humans

Male

Middle Aged

Multiple Sclerosis

Polymorphism, Single Nucleotide

Smoking

Young Adult